Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis.

Lucijanic M, Livun A, Tupek KM, Stoos-Veic T, Pejsa V, Kusec R.

Ann Hematol. 2018 Jul;97(7):1293-1294. doi: 10.1007/s00277-018-3294-9. Epub 2018 Mar 12. No abstract available.

PMID:
29532161
2.

Neck adipose tissue - tying ties in metabolic disorders.

Pandzic Jaksic V, Grizelj D, Livun A, Boscic D, Ajduk M, Kusec R, Jaksic O.

Horm Mol Biol Clin Investig. 2018 Feb 9;33(2). pii: /j/hmbci.2018.33.issue-2/hmbci-2017-0075/hmbci-2017-0075.xml. doi: 10.1515/hmbci-2017-0075. Review.

PMID:
29425108
3.

Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis.

Lucijanic M, Veletic I, Rahelic D, Pejsa V, Cicic D, Skelin M, Livun A, Tupek KM, Stoos-Veic T, Lucijanic T, Maglicic A, Kusec R.

Wien Klin Wochenschr. 2018 Feb;130(3-4):126-133. doi: 10.1007/s00508-018-1318-z. Epub 2018 Jan 25.

PMID:
29372410
4.

Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.

Lucijanic M, Mitrovic Z, Cicic D, Prka Z, Pejsa V, Livun A, Stoos-Veic T, Romic Z, Zivkovic M, Lucijanic I, Fabris Z, Kusec R.

Int J Hematol. 2018 Feb;107(2):166-172. doi: 10.1007/s12185-017-2348-4. Epub 2017 Oct 11.

PMID:
29022201
5.

High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis.

Lucijanic M, Livun A, Stoos-Veic T, Pejsa V, Jaksic O, Cicic D, Lucijanic J, Romic Z, Orehovec B, Aralica G, Miletic M, Kusec R.

Hematology. 2018 May;23(4):201-207. doi: 10.1080/10245332.2017.1376843. Epub 2017 Sep 14.

PMID:
28906207
6.

Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival.

Lucijanic M, Livun A, Tupek KM, Stoos-Veic T, Aralica G, Gecek I, Pejsa V, Kusec R.

Leuk Lymphoma. 2017 Oct;58(10):2497-2500. doi: 10.1080/10428194.2017.1296146. Epub 2017 Feb 28. No abstract available.

PMID:
28278711
7.

Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis.

Lucijanic M, Livun A, Tomasovic-Loncaric C, Stoos-Veic T, Pejsa V, Jaksic O, Prka Z, Kusec R.

Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):523-526. doi: 10.1016/j.clml.2016.06.004. Epub 2016 Jun 8.

PMID:
27381374
8.

Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome.

Lucijanić M, Pejša V, Mitrović Z, Štoos-Veić T, Livun A, Jakšić O, Vasilj T, Piršić M, Hariš V, Prka Ž, Kušec R.

Hematology. 2016 Apr;21(3):170-4. doi: 10.1080/10245332.2015.1101964. Epub 2016 Mar 30.

PMID:
27077775
9.
10.

Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.

Manshouri T, Estrov Z, Quintás-Cardama A, Burger J, Zhang Y, Livun A, Knez L, Harris D, Creighton CJ, Kantarjian HM, Verstovsek S.

Cancer Res. 2011 Jun 1;71(11):3831-40. doi: 10.1158/0008-5472.CAN-10-4002. Epub 2011 Apr 21.

11.

Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.

Stoos-Veić T, Livun A, Ajduković R, Pejsa V, Jaksić O, Kusec R.

Coll Antropol. 2010 Jun;34(2):425-9.

PMID:
20698113

Supplemental Content

Support Center